Search Results
May 14, 2026, 11:30 ET Monotype Celebrates 25 Years of Gotham with Launch of Gotham Variable, Transforming an Iconic Typeface into a Dynamic Design System
existing typeface family is no quick and easy task. Getting the proportion and style right for these new glyphs was essential to stay true to Gotham's DNA. Particularly for the hook and horn, matching Gotham's expressiveness was key," said Jordan Bell, Senior Type Designer at Monotype.Key
More news about: Monotype
May 14, 2026, 10:31 ET Professional Hair Care Market to Reach USD 57.5 billion by 2033, Growing at a CAGR of 5.3% -- Allied Market Research
professional salon services.In January 2026, Olaplex announced a strategic partnership with a leading genomics company to develop the world's first DNA-informed professional hair care regimen system, leveraging genetic biomarkers to personalize bond-repair and strengthening treatment recommendations
More news about: Allied Market Research
May 14, 2026, 09:04 ET InsideTracker Unveils New AI Platform Empowering Wellness Brands to Deliver Hyper-Personalized Health Guidance at Scale
Source-Independent: Designed for flexible interoperability across a growing wellness ecosystem, the platform integrates blood, physio, wearable, DNA, and partner data to deliver personalized guidance tailored to each partner's experience.CAMBRIDGE, Mass.,
More news about: InsideTracker
May 14, 2026, 09:00 ET Barry Callebaut Unveils Two New Innovations, Delivering a Portfolio for All Tastes and All Moments at Sweets & Snacks Expo 2026
categories.Barry Callebaut's North American President Natasha Chen said, "Innovation remains one of our global strategic pillars. Rooted in our DNA, the approach to product development is driven by experience, craftsmanship, and a deep understanding of evolving consumer preferences. By continuously
More news about: Barry Callebaut
May 14, 2026, 08:35 ET Digital Health Has Become Emotionally Embedded In Daily Life As 71% Of Americans Use Health Apps And 64% Use Health Devices, New Reach3 Insights Study Shows
that surged during the pandemic appears to be cooling, with telehealth interest declining from 48% in 2024 to 41% in 2026. Online pharmacy and DNA testing services also saw year-over-year declines."Digital health tools are becoming deeply integrated into how people manage their daily
More news about: Reach3 Insights
May 14, 2026, 08:30 ET Atossa Therapeutics to Host Virtual KOL Event Featuring Dr. Laura Esserman to Discuss Development of (Z)-Endoxifen in ER-Positive Breast Cancer
ER-positive breast cancer patientsTranslational biomarker data, including Ki-67 reduction, MRI functional tumor volume changes, and circulating tumor DNA dynamicsData supporting (Z)-endoxifen activity across clinically relevant ESR1 mutations, including Y537N, Y537S, and D538GThe rationale
More news about: Atossa Therapeutics Inc
May 14, 2026, 08:00 ET Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results
EsoGuard® Esophageal DNA Tests in 1Q26.Recognized $1.3 million in EsoGuard revenue for 1Q26.
More news about: Lucid Diagnostics
May 14, 2026, 08:00 ET Sunraycer Renewables Closes $901 Million Project Financing Facility with MUFG Bank, Ltd., Ally Bank, Nomura Securities International, Inc., Norddeutsche Landesbank Girozentrale, and Societe Generale
trusted relationships with the clients, our cutting-edge expertise, our unique innovation, our ESG capabilities and leading franchises are part of our DNA and serve our most essential objective - to deliver sustainable value creation for all our stakeholders.The Group runs three complementary
More news about: Sunraycer Renewables
May 14, 2026, 06:00 ET Ring Therapeutics® Presents its Vector Conjugate and VectorBricks™ Manufacturing Platforms at the 29th Annual American Society of Gene & Cell Therapy Conference
capsid particles with high yields.This modular platform was shown to successfully package diverse payloads including small molecules, siRNA and DNA.About Ring TherapeuticsRing is pioneering a new class of targeted medicines that deliver more. Ring's Vector Conjugate platform,
More news about: Ring Therapeutics
May 13, 2026, 21:00 ET 蒙納（Monotype）發佈 Gotham Variable，慶祝 Gotham 字體 25 週年，將經典字體升級為動態設計系統
亦新增越南文支援，補足拉丁語系中少數尚未完整涵蓋的重要語言。此版本可精準呈現複雜的變音符號、重音與聲調標記，協助品牌更清晰且真實地與更廣泛的全球受眾溝通。蒙納資深字型設計師 Jordan Bell 表示：「為既有字型家族新增語言支援並不容易。這些新字形的比例與風格必須精準拿捏，才能忠於 Gotham 的設計 DNA。尤其是彎鉤與角形等細節，如何與整體風格一致，是設計上的核心挑戰。」Gotham Variable 主要特色包括：透過單一字型檔案，實現字重與字寬的連續調整擴展語言支援，新增越南文，並強化西里爾字母與保加利亞語支援新增多種中間風格，包含更細緻的字重層次與全新
More news about: Monotype 蒙納
May 13, 2026, 20:15 ET PharmaResearch schließt westeuropäische Roadshow für REJURAN in fünf Märkten ab
Im Zuge der Einführung von REJURAN in Westeuropa diente die Roadshow als Plattform, um medizinischem Fachpersonal (HCPs) die auf der DNA-Optimierungstechnologie (DOT™) von PharmaResearch basierende Technologie sowie ihre klinischen Anwendungsmöglichkeiten vorzustellen. Nach Angaben des
More news about: PharmaResearch Co., Ltd.
May 13, 2026, 19:41 ET PharmaResearch concluye la gira de presentación de REJURAN por cinco mercados de Europa Occidental
lanzamiento en Europa Occidental, la gira de presentación sirvió de plataforma para dar a conocer a los profesionales sanitarios la tecnología basada en la 'DNA Optimizing Technology (DOT™)' de PharmaResearch y sus casos de uso clínico. La empresa señaló que los eventos despertaron un gran interés en el sector,
More news about: PharmaResearch Co., Ltd.
May 13, 2026, 16:05 ET INOVIO Reports First Quarter 2026 Financial Results and Recent Business Highlights
http://ir.inovio.com/events-and-presentations/default.aspx.About INOVIO's DNA Medicines PlatformINOVIO's DNA medicines platform has two innovative components: precisely designed DNA plasmids, delivered by INOVIO's proprietary investigational medical device, CELLECTRA. INOVIO uses proprietary technology to design its DNA plasmids, which are
More news about: INOVIO Pharmaceuticals, Inc.
May 13, 2026, 11:49 ET Beam Therapeutics Supports AlphaDetect to Accelerate Detection of Alpha-1
designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This has the potential to enable a wide range of potential therapeutic editing strategies that Beam is using to advance a diversified portfolio of base
More news about: Alpha-1 Foundation
May 13, 2026, 11:00 ET Ancestry Appoints Kelly Campbell, Former President of Peacock, to its Board of Directors
family stories. With our unparalleled collection of more than 70 billion records, over 3.8 million subscribers, and over 29 million people in our growing DNA network, customers can discover their family story and gain a new level of understanding of their lives. Over the past 40 years, we've built trusted
More news about: Ancestry
May 13, 2026, 10:30 ET Molecular Infectious Disease Testing Market worth $19.09 billion by 2031 | MarketsandMarkets™
technology. This includes several methods such as polymerase chain reaction (PCR), isothermal nucleic acid amplification, DNA sequencing, next-generation sequencing (NGS), in situ hybridization, DNA microarrays, and other advanced tests. PCR technology is one of the most commonly used methods due to its high reliability
More news about: MarketsandMarkets
May 13, 2026, 09:02 ET DELFI Diagnostics to Present First Clinical Utility Data for Blood-Based Lung Cancer Screening at ATS 2026 International Conference
DELFI Diagnostics, Inc., developer of innovative blood-based tests that leverage cell-free DNA (cfDNA) fragmentomics for cancer detection and monitoring, today announced that five abstracts featuring DELFI technology, including a late-breaker,
More news about: DELFI Diagnostics
May 13, 2026, 09:00 ET LEAP launches Bullfrog space vehicle demonstrating space logistics and global mobility
https://www.warpware.co) provided the GNC, mission design, and software.LEAP's commercial payload customers have included Princeton Cryo and GSK (DNA bank testing), CSTARS (University of Florida) for biological research, Professional Bull Riders, Major League Baseball, Sandboxx, and Megadeth.LEAP
More news about: LEAP
May 13, 2026, 09:00 ET Aura Business Announces Partnership with TD SYNNEX to Close The Unmanaged Device Security Gap
happen outside traditional IT controls."The MSP security stack today has a major gap– the human element. But, identity protection is in Aura's DNA," said Jason Coville, head of the MSP business at Aura. "Our goal is to provide MSPs with a simpler way to protect their clients without adding complexity
More news about: Aura
May 13, 2026, 08:04 ET ERS Genomics and Aurigene Sign CRISPR/Cas9 License Agreement to Advance Precision Genome Editing in Drug Discovery
accelerating innovation for our partners." CRISPR/Cas9 is a transformative genome editing technology that enables precise and efficient modification of DNA. As genome editing becomes increasingly embedded in drug discovery workflows, from target validation to cell line engineering, access to foundational
More news about: ERS Genomics
May 13, 2026, 05:00 ET Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the U.K.
Cancer Center in New York, detects actionable genomic alterations from a single blood draw and leverages state-of-the-art Ai to analyze circulating tumor DNA (ctDNA) in a minimally invasive manner.The new blood-based test offered by Synnovis can help fast-track cancer patients to receive targeted therapy
More news about: SOPHiA GENETICS
May 13, 2026, 05:00 ET Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the U.K.
Cancer Center in New York, detects actionable genomic alterations from a single blood draw and leverages state-of-the-art Ai to analyze circulating tumor DNA (ctDNA) in a minimally invasive manner.The new blood-based test offered by Synnovis can help fast-track cancer patients to receive targeted therapy
More news about: SOPHiA GENETICS
May 12, 2026, 21:02 ET PharmaResearch Completes Five-Market Western Europe Roadshow for REJURAN
As REJURAN begins its Western European rollout, the roadshow served as a platform to introduce healthcare practitioners (HCPs) to PharmaResearch's DNA Optimizing Technology (DOT™) based technology and its clinical use cases. The company said that the events drew strong interest from the industry, with
More news about: PharmaResearch Co., Ltd.
May 12, 2026, 14:55 ET Legacy Launches Upgraded At-Home Fertility Kit Featuring ProteX™ Collection Technology
cryopreservation.About LegacyLegacy is the leading male fertility clinic in the United States, offering at-home semen analysis, sperm cryopreservation, DNA fragmentation testing, and post-vasectomy testing. With a CLIA-certified, high-complexity andrology laboratory and one of the largest proprietary datasets
More news about: Give Legacy, Inc.
May 12, 2026, 11:44 ET L'ORÉAL LUXE AND DATALAND REVEAL EXCLUSIVE PARTNERSHIP TO CREATE GROUNDBREAKING OLFACTORY ART EXPERIENCE
portfolio of 30 iconic brands and 30,000 luxury experts, L'Oréal Luxe is the undisputed leader of luxury beauty, ensuring each brand preserves its unique DNA while accelerating growth.Communication L'Oréal LuxeMickael Roux, [email protected]
More news about: L'Oréal Luxe